Precision Medicine will need to get out of the pharma silo that is based on symptoms

Welcome to the digital era of biology (and to this modest blog I started in early 2005).

To cure many diseases, like cancer or cystic fibrosis, we will need to target genes (mutations, for ex.), not organs! I am convinced that the future of replacement medicine (organ transplant) is genomics (the science of the human genome). In 10 years we will be replacing (modifying) genes; not organs!

Anticipating the $100 genome era and the P4™ medicine revolution. P4 Medicine (Predictive, Personalized, Preventive, & Participatory): Catalyzing a Revolution from Reactive to Proactive Medicine.

After low-cost airlines (Ryanair, Easyjet ...) comes "low-cost" participatory medicine. Some of my readers have recently christened this long-lasting, clumsy attempt at e-writing of mine "THE LOW-COSTE INNOVATION BLOG". I am an
early adopter of scientific MOOCs. My name's Catherine Coste. I've earned myself four MIT digital diplomas: 7.00x, 7.28x1, 7.28.x2 and 7QBWx. Instructor of 7.00x: Eric Lander PhD.

Upcoming books: Airpocalypse, a medical thriller (action taking place in Beijing) 2017; Jesus CRISPR Superstar, a sci-fi -- French title: La Passion du CRISPR (2018).

I love Genomics. Would you rather donate your data, or... your vital organs?

Audio files on this blog are Windows files ; if you have a Mac, you might want to use VLC ( to read them.

Concernant les fichiers son ou audio (audio files) sur ce blog : ce sont des fichiers Windows ; pour les lire sur Mac, il faut les ouvrir avec VLC (

Presenting Journal of Mobile Technology in Medicine

The field of digital (mobile) Health (mHealth) is experiencing significant growth.  With this growth, we are witnessing some truly unique and novel solutions to healthcare issues, from iPhone based anaesthetic monitors to "smart slippers". Google Goggles are another new product which is likely to be utilized in healthcare, and it will be interesting to see where innovative minds will take such a technology.

Whilst these novel developments amongst mobile technology show great promise, it is of utmost importance that the rigors of evidence based medicine are applied. Without a strong evidence base to support a product or application, one needs to be cautious about its use. New pharmaceutical products undergo demanding testing, and their efficacy needs to be proved through appropriate studies.  Similarly, new mobile technologies should also be tested through the scientific process, and their value needs to be carefully documented.

The Journal of Mobile Technology in Medicine ( is an international peer reviewed medical journal which focuses on publishing mHealth related research. The journal is published on an open-access basis, and so all articles are available in full text free of charge. If you are interested in submitting an article for review visit our Submissions page (, or email us (

Aucun commentaire: